RSS-Feed abonnieren

DOI: 10.1055/a-2621-2515
Assessing the accuracy of magnetic resonance imaging in identifying early rectal cancers suitable for endoscopic intermuscular dissection
Authors

Abstract
Background
Selection of rectal cancers suitable for endoscopic intermuscular dissection (EID) is challenging. We aimed to evaluate whether identification of ≥1 mm of preserved muscularis propria on magnetic resonance imaging (MRI), using a systematic reporting tool (mrSRT), can identify rectal cancers suitable for EID.
Methods
An expert radiologist trained 12 study radiologists in the use of the mrSRT. The radiologists then assessed a retrospective series of MRIs from 269 consecutive patients with suspected deep submucosal invasive rectal cancer. The primary objective was to determine the diagnostic accuracy of ≥1 mm of preserved muscularis propria on MRI for selecting cases that can be resected with clear margins using EID (invasion limited to the circular muscularis propria [≤pT2circ]). Diagnostic accuracy was calculated for the expert radiologist, study radiologists, and a consensus diagnosis.
Results
After applying the inclusion and exclusion criteria, 244 patient scans were included in the analysis. Histological classification confirmed 18 lesions (7.4%) were noninvasive, 109 (44.7%) were pT1, 56 (23.0%) were pT2circ, 21 (8.6%) were pT2long, 39 (16.0%) were pT3, and 1 (0.4%) was pT4. The overall diagnostic accuracy of ≥1 mm of preserved muscularis propria as a criterion for selection was 80.7% (95%CI 75.2–85.5) for the expert radiologist, 77.5% (95%CI 71.7–82.5) for the trained study radiologists, and 81.6% (95%CI 76.1–86.2) for a consensus diagnosis.
Conclusion
Use of mrSRT to identify ≥1 mm of preserved muscularis propria on MRI allowed radiologists to assist in appropriate case selection for EID.
Publikationsverlauf
Eingereicht: 06. Dezember 2024
Angenommen nach Revision: 23. Mai 2025
Accepted Manuscript online:
26. Mai 2025
Artikel online veröffentlicht:
14. Juli 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Cardoso R, Guo F, Heisser T. et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: a population-based study in 9 countries. Lancet Reg Health Eur 2022; 21: 100458
- 2 Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E. et al. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Lancet Gastroenterol Hepatol 2022; 7: 60-68
- 3 Vermeer NCA, Backes Y, Snijders HS. et al. National cohort study on postoperative risks after surgery for submucosal invasive colorectal cancer. BJS Open 2019; 3: 210-217
- 4 Pachler J, Wille-Jørgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2012; 12: CD004323
- 5 Pucciarelli S, Giandomenico F, De Paoli A. et al. Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer. Br J Surg 2017; 104: 138-147
- 6 Moons LMG, Bastiaansen BAJ, Richir MC. et al. Endoscopic intermuscular dissection for deep submucosal invasive cancer in the rectum: a new endoscopic approach. Endoscopy 2022; 54: 993-998
- 7 Zwager LW, Bastiaansen BAJ, Montazeri NSM. et al. Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis. Gastroenterology 2022; 163: 174-189
- 8 van Oostendorp SE, Smits LJH, Vroom Y. et al. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment. Br J Surg 2020; 107: 1719-1730
- 9 Detering R, van Oostendorp SE, Meyer VM. et al. MRI cT1–2 rectal cancer staging accuracy: a population-based study. Br J Surg 2020; 107: 1372-1382
- 10 Arndt K, Vigna C, Kaul S. et al. Magnetic resonance imaging accuracy in staging early and locally advanced rectal cancer. Surg Oncol 2023; 50: 101987
- 11 Rosen R, Nilsson E, Rahman M. et al. Accuracy of MRI in early rectal cancer: National cohort study. Br J Surg 2022; 109: 570-572
- 12 Balyasnikova S, Read J, Wotherspoon A. et al. Diagnostic accuracy of high-resolution MRI as a method to predict potentially safe endoscopic and surgical planes in patients with early rectal cancer. BMJ Open Gastroenterol 2017; 4: e000151
- 13 Backes Y, Schwartz MP, Ter Borg F. et al. Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study). Gut 2019; 68: 271-279
- 14 Sano Y, Tanaka S, Kudo S-E. et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig Endosc 2016; 28: 526-533
- 15 Kudo S, Tamura S, Nakajima T. et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996; 44: 8-14
- 16 Ferlitsch M, Hassan C, Bisschops R. et al. Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2024. Endoscopy 2024; 56: 516-545
- 17 Kikuchi R, Takano M, Takagi K. et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995; 38: 1286-1295
- 18 Beets-Tan RGH, Lambregts DMJ, Maas M. et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018; 28: 1465-1475
- 19 Gormly K. Rectal MRI: the importance of high resolution T2 technique. Abdom Radiol (NY) 2021; 46: 4090-4095
- 20 Yasue C, Chino A, Takamatsu M. et al. Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions. J Gastroenterol 2019; 54: 708-717
- 21 Ronnow CF, Arthursson V, Toth E. et al. Lymphovascular infiltration, not depth of invasion, is the critical risk factor of metastases in early colorectal cancer: retrospective population-based cohort study on prospectively collected data, including validation. Ann Surg 2022; 275: E148-E154
- 22 Spadaccini M, Bourke MJ, Maselli R. et al. Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer. Gut 2022; 71: 1998-2004
- 23 Yamada M, Saito Y, Takamaru H. et al. Long-term clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms in 423 cases: a retrospective study. Endoscopy 2017; 49: 233-242
- 24 Hompes R, McDonald R, Buskens C. et al. Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome. Colorectal Dis 2013; 15: e576-581
- 25 Eid Y, Alves A, Lubrano J. et al. Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature. J Visc Surg 2018; 155: 445-452
- 26 Zinicola R, Nascimbeni R, Cirocchi R. et al. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review. Tech Coloproctol 2021; 25: 997-1010
- 27 Shaukat A, Kaltenbach T, Dominitz JA. et al. Endoscopic recognition and management strategies for malignant colorectal polyps: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 2020; 92: 997-1015 e1
- 28 Hashiguchi Y, Muro K, Saito Y. et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 2020; 25: 1-42
- 29 Suzuki C, Torkzad MR, Tanaka S. et al. The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol 2008; 6: 89
- 30 Chan BPH, Patel R, Mbuagbaw L. et al. EUS versus magnetic resonance imaging in staging rectal adenocarcinoma: a diagnostic test accuracy meta-analysis. Gastrointest Endosc 2019; 90: 196-203 e1
- 31 Luglio G, Pagano G, Tropeano FP. et al. Endorectal ultrasonography and pelvic magnetic resonance imaging show similar diagnostic accuracy in local staging of rectal cancer: an update systematic review and meta-analysis. Diagnostics (Basel) 2021; 12: 5
- 32 Marusch F, Ptok H, Sahm M. et al. Endorectal ultrasound in rectal carcinoma do the literature results really correspond to the realities of routine clinical care?. Endoscopy 2011; 43: 425-431
- 33 Ashraf S, Hompes R, Slater A. et al. A critical appraisal of endorectal ultrasound and transanal endoscopic microsurgery and decision-making in early rectal cancer. Colorectal Dis 2012; 14: 821-826
- 34 Reginelli A, Clemente A, Sangiovanni A. et al. Endorectal ultrasound and magnetic resonance imaging for rectal cancer staging: a modern multimodality approach. J Clin Med 2021; 10: 1-11
- 35 Bregendahl S, Bondeven P, Grønborg TK. et al. Training of radiology specialists in local staging of primary rectal cancer on MRI: a prospective intervention study exploring the impact of various educational elements on the interpretive performance. BMJ Open Qual 2022; 11: e001716